| Phase 2 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04815096 | Imaging Immune Activation in COVID-19 | Covid19 | Recruiting | 2026-05-08 |
| NCT03684655 | Imaging Immune Activation in HIV by PET-MR | HIV Infections | Recruiting | 2024-10-24 |
| NCT06084806 | Test-retest Evaluation of [18F]F-AraG PET | Non-small Cell Lung Cancer | Recruiting | 2024-10-24 |
| NCT06107374 | Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG | Advanced Non Small Cell Lung Cancer | Recruiting | 2024-10-24 |
| NCT07611357 | [18F]F-AraG PET Imaging in Alzheimer's Disease | Alzheimer Disease (AD) | Not Yet Recruiting | 2026-05-28 |
Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Alzheimer's Disease (1) · Dementia (1)